Characteristics, patterns of care and outcomes of patients with T-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysis
Year: 2025
Type: article
Language: en
Topic: Autoimmune and Inflammatory Disorders Research
Authors and affiliations:
raw_author_name: Till Braun
raw_affiliation_strings: First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne
Mildred Scheel School of Oncology Aachen Bonn Cologne Dusseldorf (MSSO ABCD), Faculty of Medicine, University Hospital Cologne
Mildred Scheel School of Oncology Aachen Bonn Cologne Dusseldorf (MSSO ABCD), Faculty of Medicine, University Hospital Cologne, Cologne, Germany
First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany
raw_author_name: Maren Keppel
raw_affiliation_strings: First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne
First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany
raw_author_name: Annika Dechow
raw_affiliation_strings: First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne
First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany
raw_author_name: Natali Pflug
raw_affiliation_strings: First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne
First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany
raw_author_name: Paul Liedgens
raw_affiliation_strings: First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne
First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany
raw_author_name: Marco Herling
raw_affiliation_strings: Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig and Cancer Center Central Germany
Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig and Cancer Center Central Germany, Leipzig-Jena, Germany
raw_author_name: Jan-Michel Heger
raw_affiliation_strings: First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne
Mildred Scheel School of Oncology Aachen Bonn Cologne Dusseldorf (MSSO ABCD), Faculty of Medicine, University Hospital Cologne
Mildred Scheel School of Oncology Aachen Bonn Cologne Dusseldorf (MSSO ABCD), Faculty of Medicine, University Hospital Cologne, Cologne, Germany
First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany
raw_author_name: Dennis A. Eichenauer
raw_affiliation_strings: First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne
First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany